Back to video list Back to Home How would you choose which CGRP pathway monoclonal antibody medication is for which patient and how do you convince the patient to be on eptinezumab? You may also like Mental Health Congress highlights Article Is microbiota manipulation a new therapy for psychiatric diseases? Alzheimer's Disease Congress highlights Article Who might benefit most from a personalized treatment plan to support brain health? Schizophrenia Congress highlights Article Schizophrenia and the NMDA receptor – past, present and future Mental Health Article Highlights from the 9th Congress of the European Academy of Neurology